Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuhiro Ito

Showing results (1-10 of 211) with videos related to

Pageof 22
Sort By:
Expert Opinion on Drug Delivery|May 31, 2022
Inhaled antifungal therapy: benefits, challenges, and clinical applicationsKazuhiro Ito
Antimicrobial Agents and Chemotherapy|October 26, 2017
Reply to Rojas, "The Imperative Authentication of Cell Lines"Kazuhiro Ito
Expert Review of Respiratory Medicine|January 15, 2026
Harnessing innate immunity to prevent viral exacerbations: current strategies and future directions for chronic inflammatory lung disease managementKazuhiro Ito
Expert Review of Anti-Infective Therapy|July 4, 2025
Can inhaled antifungals provide a viable solution for treatment-refractory pulmonary fungal infections?Kazuhiro Ito
American Journal of Respiratory Cell and Molecular Biology|August 4, 2021
HDAC6: A Neglected Player in Chronic Obstructive Pulmonary Disease?Kazuhiro Ito
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|August 23, 2006
[Ubiquitin in Alzheimer's disease]Hiroshi Mori, Kazuhiro Ito
Expert Opinion on Therapeutic Targets|August 8, 2009
Therapeutic targets for new therapy for corticosteroid refractory asthmaKazuhiro Ito, Nicolas Mercado
Experimental Gerontology|April 9, 2014
STOP accelerating lung aging for the treatment of COPDKazuhiro Ito, Nicolas Mercado
American Journal of Respiratory Cell and Molecular Biology|February 29, 2020
Fighting the Common Cold: ORMDL3 in the Crosshairs?Kazuhiro Ito, Youming Zhang
Revista Portuguesa De Pneumologia|May 13, 2015
COPD as a disease of accelerated lung aging(a)Kazuhiro Ito, Peter J Barnes
Pageof 22

Showing results (1-10 of 211) with videos related to

Sort By:
Pageof 22
Expert Opinion on Drug Delivery|May 31, 2022
Inhaled antifungal therapy: benefits, challenges, and clinical applicationsKazuhiro Ito
Antimicrobial Agents and Chemotherapy|October 26, 2017
Reply to Rojas, "The Imperative Authentication of Cell Lines"Kazuhiro Ito
Expert Review of Respiratory Medicine|January 15, 2026
Harnessing innate immunity to prevent viral exacerbations: current strategies and future directions for chronic inflammatory lung disease managementKazuhiro Ito
Expert Review of Anti-Infective Therapy|July 4, 2025
Can inhaled antifungals provide a viable solution for treatment-refractory pulmonary fungal infections?Kazuhiro Ito
American Journal of Respiratory Cell and Molecular Biology|August 4, 2021
HDAC6: A Neglected Player in Chronic Obstructive Pulmonary Disease?Kazuhiro Ito
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|August 23, 2006
[Ubiquitin in Alzheimer's disease]Hiroshi Mori, Kazuhiro Ito
Expert Opinion on Therapeutic Targets|August 8, 2009
Therapeutic targets for new therapy for corticosteroid refractory asthmaKazuhiro Ito, Nicolas Mercado
Experimental Gerontology|April 9, 2014
STOP accelerating lung aging for the treatment of COPDKazuhiro Ito, Nicolas Mercado
American Journal of Respiratory Cell and Molecular Biology|February 29, 2020
Fighting the Common Cold: ORMDL3 in the Crosshairs?Kazuhiro Ito, Youming Zhang
Revista Portuguesa De Pneumologia|May 13, 2015
COPD as a disease of accelerated lung aging(a)Kazuhiro Ito, Peter J Barnes
Pageof 22